SCHEMBL31353035

SCHEMBL31353035

NC(=O)C1CCCO1.[Na]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1372796 0.98
SCHEMBL745665 0.98
SCHEMBL1374483 0.98
Fluoride SCHEMBL28317693 0.98
Hydrochloric Acid SCHEMBL3992747 0.95
Hydrochloric Acid SCHEMBL12469432 0.95
SCHEMBL18474377 0.91
SCHEMBL4492294 0.91
SCHEMBL546913 0.91
Sulfuric Acid SCHEMBL28773568 0.89 NOS2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103316-A1 TETRAHYDROFURAN-FORMAMIDE SODIUM CHANNEL MODULATOR AND USE THEREOF IN MEDICINE 嘉兴安帝康生物科技有限公司 2026-05-21 WO disclosed
CN-119143737-B Tetrahydrofuran carboxamide sodium channel regulator and application thereof in medicine 嘉兴安帝康生物科技有限公司 2025-07-18 CN disclosed
CN-119143737-A Tetrahydrofuran carboxamide sodium channel regulator and application thereof in medicine 嘉兴安帝康生物科技有限公司 2024-12-17 CN disclosed
CN-119143737-A Tetrahydrofuran carboxamide sodium channel regulator and application thereof in medicine 嘉兴安帝康生物科技有限公司 2024-12-17 CN disclosed